CIK: 1721749 - Address: C/o Innovate Biopharmaceuticals, Inc.,, 8480 Honeycutt Road, Suite 120, Raleigh, NC 27615
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/29/18 20:00
11/29/18
INNTInnovate Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPrior Christopher P.NCDOCEOP142.75052497D
9/14/18 18:58
9/14/18
INNTInnovate Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPrior Christopher P.NCDOCEOP15.8200112D
9/13/18 18:00
9/12/18
INNTInnovate Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPrior Christopher P.NCDOCEOP36.1301382D
8/30/18 20:39
8/30/18
INNTInnovate Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPrior Christopher P.NCDOCEOP25.2000311D
8/28/18 18:19
8/28/18
INNTInnovate Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsPrior Christopher P.NCDOCEOP54.9301New1D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact